ClinicalTrials.Veeva

Menu
S

SSAK Partners, LLC | Coral Springs, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Rinzimetostat
ORIC-944
Abiraterone Acetate
BNT327

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 3 total trials

A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

Himalayas-1 is a randomized, open-label, global, multicenter phase 3 study evaluating whether the combination of rinzimetostat with darolutamide is m...

Enrolling
Metastatic Castration Resistant Prostate Cancer
Drug: Rinzimetostat
Drug: Enzalutamide

This is a Phase 2/3, multisite, randomized, open-label study in participants with first-line non-small cell lung cancer (NSCLC).This study includes t...

Enrolling
Non-small Cell Lung Cancer
Drug: Pembrolizumab
Drug: Paclitaxel

This is a prospective, multicenter, open-label, single-arm study to assess the efficacy, safety, and pharmacokinetics (PK) of IgPro20 in adults with...

Enrolling
Secondary Immune Deficiency
Biological: IgPro20

Trial sponsors

BioNTech logo
CSL Behring logo
O

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems